Skip to main content

Table 1 Baseline demographic and clinical characteristics of the participants

From: Health-related quality of Life in patients with chronic hepatitis C receiving Sofosbuvir-based treatment, with and without Interferon: a prospective observational study in Egypt

 

Number (total 62)

Percent

Age

54.06 ± 10.41*

Gender

 • Males

30

48.40

 • Females

32

51.60

Education

 • Uneducated

24

38.70

 • Can read and write or preparatory

12

29.00

 • Secondary

12

19.40

 • University

8

12.90

Marital status

 • Unmarried

17

27.40

 • Married

45

72.60

Employment status

 • Unemployed

17

27.40

 • Employed

17

27.40

 • Housewife

28

45.20

Residence area

 • Rural

15

24.20

 • Urban

47

75.80

Diseases stage

 • Non cirrhotic

31

50

 • Cirrhotic

31

50

Number of comorbidities

 • 0

31

50

 • 1

17

27.4

 • 2

11

17.7

 • 3

3

4.8

Type of comorbidity

 • Hypertension

15

24.20

 • Diabetes

19

30.60

 • Others (renal disease, disc, heart disease, asthma, peptic ulcer)

11

17.70

Disease duration (Range from 3 to 216 months)

71.10 ± 57.72*

Type of treatment

 • Dual

31

50

 • Triple

31

50

Treatment experience

 • Naive

54

87.10

 • Experienced

8

12.90

Treatment paying method

 • Self

6

9.70

 • Governmental

56

90.30

BMI

 T0

30.6 ± 4.24*

 T1

30.4 ± 4.53*

PCR at T1 (50 cases)

 • Negative

32

64

 • Positive

18

36

  1. BMI body mass index, PCR Polymerase Chain Reaction, T0 Time 0, T1 time 1
  2. *Mean ± SD
  3. *P value: * ≤ .05 at two tailed